398
D.L. Chizhov et al. / Journal of Fluorine Chemistry 132 (2011) 394–401
4.2. General procedure for synthesis of tridentate
b
-aminoenones 2a–c
d d 11.98 (s, CH2CH3), 25.67
84.88 (s). 13C NMR (100 MHz, CDCl3):
(s, CH2CH3), 89.80 (q, 3J = 0.8 Hz, 55CH–), 117.25 (q, 1J = 288.4 Hz,
CF3), 127.80 (s, CH, Ar), 128.72 (s, CH, Ar), 133.22 (s, Ar), 173.58 (s,
55C(NHAr)–), 178.03 (q, 2J = 33.7 Hz, CF3C55O). EIMS (probe)
70 eV, m/z (rel. int.): 408 [M]+ (6), 389 [MꢂF]+ (2), 379 [MꢂC2H5]+
o-Phenylenediamine (0.55 g, 5.1 mmol), B(OEt)3 (0.75 g,
5.14 mmol) and 1,3-diketone 1a–c (5.0 mmol) in CH3CN (20 mL)
were stirred 10–15 min, diluted with water (50 mL) and stirred
until solidification of a precipitated oil. The solid was collected,
washed with water, dried in the air, dissolved in CHCl3 (3 mL), and
passed through silica gel bed (2 cm). Silica gel was washed with
CHCl3 (3 ꢃ 5 mL). Combined chloroform solutions were evaporat-
ed. The residue was recrystallized from hexane–CH2Cl2 (3:1)
solution. Yields of 2a–c are collected in the Table 1.
+
(100), 369 [MꢂFꢂHF]+ (1), 339 [MꢂCF3]+ (4), 311 [MꢂCF3CO]+
(2), 297 [MꢂCF3COCH2]+ (92), 229 [C10H8N2OF3]+ (25). Anal. Calcd
for C18H18N2F6O2: C, 52.99; H, 4.39; N, 6.87; F, 27.94. Found C,
53.08; H, 4.69; N, 6.79; F, 28.05.
(Z)-5,5,6,6,7,7,7-Heptafluoro-2-(2-{[(Z)-4,4,5,5,6,6,6-hepta-
fluoro-1-methyl-3-oxo-1-hexenyl]amino}anilino)-2-hepten-4-
one (compound H2L3). Yellow crystals: mp 85–86 8C. IR (DRA):
n
(Z)-4-(2-aminoanilino)-1,1,1-trifluoro-3-penten-2-one (com-
pound 2a). Pale-yellow crystals: mp 96-97 8C [96-97 8C, ref. [12c].
(Z)-4-(2-aminoanilino)-1,1,1-trifluoro-3-hexen-2-one (com-
3123 (NH. . .O55), 1618, 1604, 1582, 1517 (O55C–C55C, Ar), 1481,
1434 ( 2.05 (6H, s,
CH). 1H NMR spectral data (400 MHz, CDCl3):
2CH3), 5.64 (2H, s, 2 = CH), 7.31–7.33 (2H, m, Ar), 7.41–7.44 (2H, m,
Ar), 12.47 (2H, br. s, 2NH). 19F NMR (376 MHz, CDCl3):
34.57 (s,
d
d
pound 2b). Pale-yellow crystals: mp 98–99 8C. IR (DRA):
3358 (NH2), 3225 (NH. . .O55), 1629, 1619, 1596, 1500 (O55C–C55C,
Ar). 1H NMR spectral data (CDCl3,
/ppm, J/Hz) 1.10 (t, 3H, J = 7.5,
n 3455,
d
d
d
4F, 2CF2CF2CF3), 40.29 (q, 4F, J = 8.8 Hz, 2CF2CF2CF3), 80.96 (t, 6F,
J = 8.8 Hz, 2CF2CF2CF3). 13C NMR (100 MHz, CDCl3): 19.89 (s, CH3),
93.34 (t, 3J = 1.0 Hz, 55CH–), 108.71 (tq, 1J = 265.9, 2J = 38.3 Hz,
CF3CF2CF2), 109.37 (tt, 1J = 264.9, 2J = 31.0 Hz, CF3CF2CF2), 117.73
(qt, 1J = 287.8, 2J = 34.1 Hz, CF3CF2CF2), 127.59 (s, CH, Ar), 128.74 (s,
CH, Ar), 133.12 (s, Ar), 167.64 (s, 55C(NHAr)–), 178.73 (t,
2J = 24.4 Hz, CF3C55O). EIMS (probe) 70 eV, m/z (rel. int.): 580
[M]+ (4), 561 [MꢂF]+ (1), 565 [MꢂCH3]+ (12), 541 [MꢂFꢂHF]+ (1),
383 [MꢂC3F7CO]+ (4), 369 [MꢂC3F7COCH2]+ (100), 356
[MꢂC3F7COCH55CH2]+ (6), 329 [C12H8N2OF7]+ (7). Anal. Calcd for
CH3), 2.30 (2H, q, J = 7.5, CH2), 3.80 (2H, br.s, NH2), 5.60 (1H, s,
55CH), 6.75–6.81 (2H, m, Ar), 6.99–7.01 (m, 1H, Ar), 7.15–7.19 (m,
1H, Ar), 12.05 (1H, br.s, NH). 19F NMR (376 MHz, CDCl3):
d 84.88 (s).
Anal. Calcd for C12H13N2F3O: C, 55.81; H, 5.07; N, 10.85; F, 22.07.
Found: C, 55.58; H, 5.06; N, 10.74; F, 22.20.
(Z)-2-(2-aminoanilino)-5,5,6,6,7,7,7-heptafluoro-2-hepten-4-
one (compound 2c). Pale-yellow crystals: mp 80–81 8C. IR (DRA):
3469, 3374 (NH2), 1612, 1585, 1567, 1518, 1500, 1429 (O55C–C55C,
Ar). 1H NMR spectral data (CDCl3,
/ppm, J/Hz) 2.02 (s, 3H, CH3),
n
d
d
3.80 (2H, br. s, NH2), 5.62 (1H, s,55CH), 6.76–6.82 (2H, m, Ar), 7.00–
7.02 (1H, m, Ar), 7.14–7.19 (1H, m, Ar), 12.12 (1H, br. s, NH). 19F
C20H14N2F14O2: C, 41.42; H, 2.43; N, 4.83; F, 45.86. Found C, 41.38;
H, 2.44; N, 4.90; F, 45.91.
NMR (376 MHz, CDCl3):
d 34.93 (s, 2F, CF2CF2CF3), 40.83 (q, 2F,
J = 8.8 Hz, CF2CF2CF3), 81.16 (t, 3F, J = 8.8 Hz, CF2CF2CF3). Anal.
Calcd for C13H11N2F7O: C, 45.36; H, 3.22; N, 8.14; F, 38.63. Found: C,
45.43; H, 2.81; N, 8.22; F, 38.72.
4.4. General procedure for synthesis of unsymmetrical bis(b-
aminoenones) H2L4,5
A
solution of
b-methoxyenone 3 (0.20 g, 1.2 mmol) and
4.3. General procedure for synthesis of symmetrical bis(
b
-
corresponding -aminoenone 2b,c (1.0 mmol) in pyridine (2 mL)
b
aminoenones) H2L1–3
was stirred for 2 days (TLC control), dried in vacuum and purified
via a copper complex as described above. Yields of H2L4,5 are given
in the Table 1.
To a solution of o-phenylenediamine (0.162 g, 1.5 mmol) in
B(OBu)3 (3.5 g, 15.2 mmol) 1,3-diketone 1a–c (3.2 mmol) was
added and stirred 1–3 days until disappearance of an aminoenone
2 (TLC). Then CHCl3 (10 mL) and water (20 mL) were added and
stirred 5 min. Water layer was separated and extracted with
CHCl3 (3 ꢃ 5 mL). The combined organic solution were evaporated
and stirred with suspension of copper acetate (1.5 g) in CH3CN
(20 mL) for 3 h. Then water (50 mL) was added, a precipitation
was filtered off, washed with water, dried in the air, and
chromatographed (eluent CHCl3). The obtained solution was
concentrated to ca. 10 mL, and oxalic acid (1.0 g) was added. The
suspension was stirred until the green colour disappeared and
then passed through a silica gel bed (2 cm). Silica gel was washed
with CHCl3 (3 ꢃ 5 mL) and combined chloroform solutions were
evaporated to afford analytically pure product. Yields of H2L1–3
are shown in the Table 1.
(Z)-1,1,1-Trifluoro-4-(2-{[(Z)-4,4,4-trifluoro-1-methyl-3-oxo-
1-butenyl]amino}anilino)-3-penten-2-one (compound H2L1). Yel-
low crystals: mp 123–124 8C [122–124 8C, ref. [12c]. EIMS (probe)
70 eV, m/z (rel. int.): 380 [M]+ (13), 361 [MꢂF]+ (1), 365 [MꢂCH3]+
(16), 341 [MꢂFꢂHF]+ (1), 311 [MꢂCF3]+ (4), 283 [MꢂCF3CO]+ (3),
269 [MꢂCF3COCH2]+ (100), 256 [MꢂCF3COCHCH2]+ (6), 229
[C10H8N2OF3]+ (9).
(Z)-1,1,1-Trifluoro-4-(2-{[(Z)-4,4,4-trifluoro-1-methyl-3-oxo-
1-butenyl]amino}anilino)-3-hexen-2-one
(compound
H2L4).
Light-yellow crystals: mp 61–62 8C. IR (DRA):
n
3153 (N–
Hꢁ ꢁ ꢁO55), 1606, 1586, 1562, 1515 (O55C–C55C, Ar), 1485, 1436 (
d
CH). 1H NMR spectral data (400 MHz, CDCl3):
d
1.13 (3H, t,
J = 7.5 Hz, CH3), 2.07 (3H, s, CH3), 2.32 (2H, q, J = 7.5 Hz, CH2), 5.60
and 5.62 (every 1H, two s, 2 = CH), 7.26–7.32 (2H, m, Ar), 7.41–7.43
(2H, m, Ar), 12.31 and 12.33 (every 1H, two br. s, 2NH). 19F NMR
(376 MHz, CDCl3):
(100 MHz, CDCl3):
d
d
84.79 (s, 3F, CF3), 84.88 (s, 3F, CF3). 13C NMR
11.96 (s, CH2CH3), 19.95 (s, CH3), 25.64 (s,
CH2CH3), 89.84 (q, 3J = 1.3 Hz, 55CH–), 91.95 (q, 3J = 1.3 Hz, 55CH–),
117.21 (q, 1J = 288.2 Hz, CF3), 117.28 (q, 1J = 288.2 Hz, CF3), 127.41,
127.9, 128.56, 128.74 (four singlets, CH, Ar), 132.93, 133.46 (two
singlets, Ar), 167.80 (s,55C(NHAr)–), 173.65 (s,55C(NHAr)–), 177.70
(q, 2J = 33.7 Hz, CF3C55O), 178.11 (q, 2J = 33.7 Hz, CF3C55O). EIMS
(probe) 70 eV, m/z (rel. int.): 394 [M]+ (10), 375 [MꢂF]+ (2), 379
[MꢂCH3]+ (8), 365 [MꢂC2H5]+ (61), 355 [MꢂFꢂHF]+ (1), 325
[MꢂCF3]+ (4), 297 [MꢂCF3CO]+ (2), 283 [MꢂCF3COCH2]+ (100), 270
[MꢂCF3COCH55CH2]+ (2), 256 [C12H11N2OF3]+ (2), 229
[C10H8N2OF3]+ (16). Anal. Calcd for C17H16N2F6O2: C, 51.82; H,
4.09; N, 7.08; F, 28.93. Found C, 51.79; H, 4.04; N, 7.11; F, 28.99.
(Z)-5,5,6,6,7,7,7-Heptafluoro-2-(2-{[(Z)-4,4,4-trifluoro-1-
(Z)-4-(2-{[(Z)-1-ethyl-4,4,4-trifluoro-3-oxo-1-butenyl]ami-
no}anilino)-1,1,1-trifluoro-3-hexen-2-one (compound H2L2). Yel-
methyl-3-oxo-1-butenyl]amino}anilino)-2-hepten-4-one (com-
pound H2L5). Yellow viscous oil. IR (DRA):
n
3149 (NH. . .O55),
1614, 1599, 1583, 1519 (O55C–C55C, Ar), 1484, 1436 (
CH). 1H NMR
spectral data (400 MHz, CDCl3): 2.05 and 2.07 (every 3H, two s,
low crystals: mp 73–74 8C. IR (DRA):
1585, 1513 (O55C–C55C, . . .Ar), 1489, 1452 (
data (400 MHz, CDCl3): 1.13 (6H, t, J = 7.5 Hz, 2CH3), 2.32 (4H, q,
n
3145 (NH. . .O55), 1600,
d
d
CH). 1H NMR spectral
d
d
2CH3), 5.59 and 5.66 (every 1H, two s, 2 = CH), 7.30–7.33 (2H, m,
Ar), 7.41–7.43 (2H, m, Ar), 12.35 and 12.47 (every 1H, two br. s,
2NH). 19F NMR (376 MHz, CDCl3):
d 34.61 (s, 2F, CF2CF2CF3), 40.35
J = 7.5 Hz, 2CH2), 5.62 (2H, s, 2 = CH), 7.30–7.33 (2H, m, Ar), 7.41–
7.44 (2H, m, Ar), 12.31 (2H, br. s, 2NH). 19F NMR (376 MHz, CDCl3):